ATE218877T1 - Bowman-birk-inhibitorzusammensetzungen zur behandlung von entzündungskrankheiten - Google Patents
Bowman-birk-inhibitorzusammensetzungen zur behandlung von entzündungskrankheitenInfo
- Publication number
- ATE218877T1 ATE218877T1 AT96926120T AT96926120T ATE218877T1 AT E218877 T1 ATE218877 T1 AT E218877T1 AT 96926120 T AT96926120 T AT 96926120T AT 96926120 T AT96926120 T AT 96926120T AT E218877 T1 ATE218877 T1 AT E218877T1
- Authority
- AT
- Austria
- Prior art keywords
- bowman
- inflammatory diseases
- treating inflammatory
- birk inhibitor
- inhibitor compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/56—Protease inhibitors from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Botany (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/507,044 US5614198A (en) | 1995-07-25 | 1995-07-25 | Bowman-Birk Inhibitor compositions for treatment of inflammatory disease |
| PCT/US1996/012173 WO1997004792A1 (en) | 1995-07-25 | 1996-07-25 | Bowman-birk inhibitor compositions for treatment of imflammatory disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE218877T1 true ATE218877T1 (de) | 2002-06-15 |
Family
ID=24017040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96926120T ATE218877T1 (de) | 1995-07-25 | 1996-07-25 | Bowman-birk-inhibitorzusammensetzungen zur behandlung von entzündungskrankheiten |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5614198A (de) |
| EP (1) | EP0841933B1 (de) |
| JP (1) | JP4026851B2 (de) |
| KR (1) | KR19990035906A (de) |
| AT (1) | ATE218877T1 (de) |
| AU (1) | AU703476B2 (de) |
| CA (1) | CA2223968A1 (de) |
| DE (1) | DE69621805T2 (de) |
| DK (1) | DK0841933T3 (de) |
| ES (1) | ES2176475T3 (de) |
| NO (1) | NO980289D0 (de) |
| PT (1) | PT841933E (de) |
| WO (1) | WO1997004792A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040166183A1 (en) * | 1998-05-20 | 2004-08-26 | Ruseler-Van Embden Johanna G. H. | Methods and means for preventing or treating inflammation or pruritis |
| EP0958833A1 (de) * | 1998-05-20 | 1999-11-24 | Erasmus Universiteit Rotterdam | Verfahren und Mittel zur Vorbeugung oder Behandlung der Entzündung |
| DE19906108A1 (de) * | 1999-02-13 | 2000-08-17 | Univ Eberhard Karls | Schutz von Zellen im Zusammenhang mit einer Behandlung mit chemischen Agenzien |
| US6391848B1 (en) * | 1999-04-30 | 2002-05-21 | The Regents Of The University Of California | Soybean protein nutraceuticals |
| US6767564B2 (en) * | 2000-09-02 | 2004-07-27 | The Trustees Of The University Of Pennsylvania | Use of bowman birk inhibitor for the treatment of multiple sclerosis and other autoimmune diseases |
| US20080025966A1 (en) * | 2004-01-30 | 2008-01-31 | Currie Mark G | Methods And Compositions For The Treatment Of Gastrointestinal disorders |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4793996A (en) * | 1984-11-14 | 1988-12-27 | Ann R. Kennedy | Method of making soybean extract inhibitor |
| JPS6351335A (ja) * | 1986-08-20 | 1988-03-04 | Fuji Oil Co Ltd | 肥満細胞脱顆粒抑制剤 |
| US5217717A (en) * | 1990-09-06 | 1993-06-08 | Central Soya Company, Inc. | Method of making soybean Bowman-Birk inhibitor concentrate and use of same as a human cancer preventative and therapy |
| US5376373A (en) * | 1990-09-06 | 1994-12-27 | Trustees Of The University Of Pennsylvania | Method of inhibiting radiation induced weight and hair loss |
| EP0512090B2 (de) * | 1990-10-16 | 2006-11-22 | Sonoran Desert Chemicals LLC | Behandlung von entzündungen |
| IT1252865B (it) * | 1991-12-31 | 1995-06-28 | Lifegroup Spa | N-acilderivati di aminoalcooli attivi come autocoidi locali ed utilizzabili nella terapia dei processi autoimmuni |
| SE9301911D0 (sv) * | 1993-06-03 | 1993-06-03 | Ab Astra | New peptide derivatives |
-
1995
- 1995-07-25 US US08/507,044 patent/US5614198A/en not_active Expired - Lifetime
-
1996
- 1996-07-25 CA CA002223968A patent/CA2223968A1/en not_active Abandoned
- 1996-07-25 DK DK96926120T patent/DK0841933T3/da active
- 1996-07-25 ES ES96926120T patent/ES2176475T3/es not_active Expired - Lifetime
- 1996-07-25 DE DE69621805T patent/DE69621805T2/de not_active Expired - Fee Related
- 1996-07-25 EP EP96926120A patent/EP0841933B1/de not_active Expired - Lifetime
- 1996-07-25 WO PCT/US1996/012173 patent/WO1997004792A1/en active IP Right Grant
- 1996-07-25 JP JP50770897A patent/JP4026851B2/ja not_active Expired - Lifetime
- 1996-07-25 KR KR1019980700567A patent/KR19990035906A/ko not_active Application Discontinuation
- 1996-07-25 AU AU66501/96A patent/AU703476B2/en not_active Ceased
- 1996-07-25 AT AT96926120T patent/ATE218877T1/de not_active IP Right Cessation
- 1996-07-25 PT PT96926120T patent/PT841933E/pt unknown
-
1998
- 1998-01-22 NO NO980289A patent/NO980289D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997004792A1 (en) | 1997-02-13 |
| EP0841933A4 (de) | 1998-08-05 |
| NO980289L (no) | 1998-01-22 |
| EP0841933A1 (de) | 1998-05-20 |
| EP0841933B1 (de) | 2002-06-12 |
| AU703476B2 (en) | 1999-03-25 |
| DE69621805T2 (de) | 2003-03-20 |
| JPH11510166A (ja) | 1999-09-07 |
| DK0841933T3 (da) | 2002-07-15 |
| AU6650196A (en) | 1997-02-26 |
| DE69621805D1 (de) | 2002-07-18 |
| KR19990035906A (ko) | 1999-05-25 |
| US5614198A (en) | 1997-03-25 |
| CA2223968A1 (en) | 1997-02-13 |
| ES2176475T3 (es) | 2002-12-01 |
| JP4026851B2 (ja) | 2007-12-26 |
| NO980289D0 (no) | 1998-01-22 |
| PT841933E (pt) | 2002-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69837295D1 (de) | Probucolbernsteinsäureester zur Hemmung der Expression von VCAM-1 | |
| DE69509544D1 (de) | Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten | |
| ATE230757T1 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
| DE69733132D1 (de) | Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen | |
| ATE215366T1 (de) | 3-benzoylphenylessigsäure-derivate enthaltende topische zusammensetzungen zur behandlung der ophthalmischen entzündungserkrankungen | |
| ATE198044T1 (de) | Hydroperoxeicosatetraensäure derivate enthaltende zusammensetzungen und verfahren zur verwendung zur behandlung des trockenen auges | |
| DE69728594D1 (de) | Chromfreie Zusammensetzung zur Behandlung von Metalloberflächen | |
| DE69724016D1 (de) | Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege | |
| DE60027016D1 (de) | Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis | |
| DE69530860D1 (de) | Behandlung der entzündung des sehnervs | |
| DE69603089D1 (de) | Zusammensetzung zur behandlung von mauerwerk | |
| ATE342278T1 (de) | Verfahren zur behandlung von diabetes mittels kgf | |
| DK1039912T3 (da) | Angiostatiske midler og præparater til behandling af GLC1A-glaukom | |
| DE69634951D1 (de) | Topische verwendung von betulinsäure zur behandlung bösartiger melanome | |
| DE69519577D1 (de) | Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes | |
| DE69214610D1 (de) | Verfahren zur Behandlung von Erdgas | |
| DE69707033D1 (de) | Verfahren zur Behandlung von Gasen die Organohalogenzusammensetzungen enthalten | |
| DE69720996D1 (de) | Neue pharmazeutische zusammensetzungen von steroid-nitratester zur verwendung als enzündungshemmer | |
| DE69405919D1 (de) | Zusammensetzungen zur Behandlung von Keratinfasern | |
| ATE218877T1 (de) | Bowman-birk-inhibitorzusammensetzungen zur behandlung von entzündungskrankheiten | |
| DE69913380D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen | |
| ATE338566T1 (de) | Aldosteronantagonist und cyclooxygenase-2 hemmer- kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten | |
| TR199700435A2 (xx) | Pestisit florolefin bile�imlerinin haz�rlanmas� i�in i�lem ve ara bile�imler. | |
| ATE236633T1 (de) | Topische verwendung von loperamid zur behandlung mikrobieller infektionen | |
| NO953522D0 (no) | Sammensetninger og fremgangsmåter for behandling av immunomedierte inflammatoriske sykdommer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |